Your browser doesn't support javascript.
loading
Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AKI.
Pushpan, Chithra K; Kresock, Daniel F; Ingersoll, Matthew A; Lutze, Richard D; Keirns, Darby L; Hunter, William J; Bashir, Khalid; Teitz, Tal.
Affiliation
  • Pushpan CK; Department of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska.
  • Kresock DF; Department of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska.
  • Ingersoll MA; Department of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska.
  • Lutze RD; Department of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska.
  • Keirns DL; Department of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska.
  • Hunter WJ; Department of Pathology, Creighton University School of Medicine, Omaha, Nebraska.
  • Bashir K; Renal Division, Department of Medicine, CHI Nephrology and Creighton University Medical Center, Omaha, Nebraska.
  • Teitz T; Department of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, Nebraska.
J Am Soc Nephrol ; 35(1): 22-40, 2024 01 01.
Article in En | MEDLINE | ID: mdl-37962623

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Kidney Injury / Hearing Loss / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Kidney Injury / Hearing Loss / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2024 Document type: Article